MENU
CCCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

C4 Therapeutics (CCCC) Ownership - Who owns C4 Therapeutics?

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives... Show more

Profile

Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
183.62M
P/E Ratio
N/A
Total Cash
214.55M
Projected Growth
N/A
Total Debt
62.92M
Revenue
34.24M
Risk (Beta)
3.53
Dividend Yield
N/A
Total Cash/Share
3.01
Total Debt/Equity
N/A
Revenue/Share
0.49 USD as % of share price

Fundamentals

CCCC
Capitalization
184M
P/E Ratio
N/A
Risk (Beta)
3.53
Dividend Yield
N/A
Total Cash
215M
Total Cash/Share
3.01
Total Debt
62.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.49%
Revenue
34.2M
ROE
N/A
Book Value
174M
P/B Ratio
1.05
Cash Flow
N/A
Earnings
-1.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
5.06
Current Revenue Per Employee
58754.55
Dividends Per Share - Security
N/A
EBITDA
-109.63M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-32.93
Shares Held By Institutions
109M
Shares Outstanding - Current
71.2M
Total Liabilities
122M
Total Volume MTD
N/A
Value
1
Gain YTD
-29.167
View a ticker or compare two or three
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CCCC showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
145
Web
https://www.c4therapeutics.com